These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22891867)
1. Antitumor activity of the tea polyphenol epigallocatechin-3-gallate encapsulated in targeted vesicles after intravenous administration. Lemarié F; Chang CW; Blatchford DR; Amor R; Norris G; Tetley L; McConnell G; Dufès C Nanomedicine (Lond); 2013 Feb; 8(2):181-92. PubMed ID: 22891867 [TBL] [Abstract][Full Text] [Related]
2. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate. Ray L; Kumar P; Gupta KC Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370 [TBL] [Abstract][Full Text] [Related]
3. Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles. Fu JY; Blatchford DR; Tetley L; Dufès C J Control Release; 2009 Dec; 140(2):95-9. PubMed ID: 19709637 [TBL] [Abstract][Full Text] [Related]
4. Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. Fang JY; Lee WR; Shen SC; Huang YL J Dermatol Sci; 2006 May; 42(2):101-9. PubMed ID: 16423506 [TBL] [Abstract][Full Text] [Related]
5. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995 [TBL] [Abstract][Full Text] [Related]
6. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163 [TBL] [Abstract][Full Text] [Related]
8. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482 [TBL] [Abstract][Full Text] [Related]
9. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Liang G; Tang A; Lin X; Li L; Zhang S; Huang Z; Tang H; Li QQ Int J Oncol; 2010 Jul; 37(1):111-23. PubMed ID: 20514403 [TBL] [Abstract][Full Text] [Related]
10. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343 [TBL] [Abstract][Full Text] [Related]
11. Tumor regression after intravenous administration of targeted vesicles entrapping the vitamin E α-tocotrienol. Karim R; Somani S; Al Robaian M; Mullin M; Amor R; McConnell G; Dufès C J Control Release; 2017 Jan; 246():79-87. PubMed ID: 27993600 [TBL] [Abstract][Full Text] [Related]
12. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Gensler HL; Timmermann BN; Valcic S; Wächter GA; Dorr R; Dvorakova K; Alberts DS Nutr Cancer; 1996; 26(3):325-35. PubMed ID: 8910914 [TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin. Katiyar SK; Agarwal R; Wang ZY; Bhatia AK; Mukhtar H Nutr Cancer; 1992; 18(1):73-83. PubMed ID: 1408948 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin. Dvorakova K; Dorr RT; Valcic S; Timmermann B; Alberts DS Cancer Chemother Pharmacol; 1999; 43(4):331-5. PubMed ID: 10071985 [TBL] [Abstract][Full Text] [Related]
15. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways. Chen NG; Lu CC; Lin YH; Shen WC; Lai CH; Ho YJ; Chung JG; Lin TH; Lin YC; Yang JS Oncol Rep; 2011 Oct; 26(4):939-47. PubMed ID: 21743966 [TBL] [Abstract][Full Text] [Related]
16. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027 [TBL] [Abstract][Full Text] [Related]
17. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Ahmad N; Cheng P; Mukhtar H Biochem Biophys Res Commun; 2000 Aug; 275(2):328-34. PubMed ID: 10964666 [TBL] [Abstract][Full Text] [Related]
18. Novel tocotrienol-entrapping vesicles can eradicate solid tumors after intravenous administration. Fu JY; Zhang W; Blatchford DR; Tetley L; McConnell G; Dufès C J Control Release; 2011 Aug; 154(1):20-6. PubMed ID: 21539872 [TBL] [Abstract][Full Text] [Related]
19. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles. Hsieh DS; Wang H; Tan SW; Huang YH; Tsai CY; Yeh MK; Wu CJ Biomaterials; 2011 Oct; 32(30):7633-40. PubMed ID: 21782236 [TBL] [Abstract][Full Text] [Related]
20. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]